St Germain D J CO Inc Pfizer Inc Transaction History

St Germain D J CO Inc

  • $2.4 Billion
  • Q3 2025

A detailed history of St Germain D J CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, St Germain D J CO Inc holds 29,042 shares of PFE stock, worth $715,885. This represents 0.03% of its overall portfolio holdings.

Number of Shares
29,042
Previous 28,373 2.36%
Holding current value
$715,885
Previous $687,000 7.57%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025
BUY
$23.29 - $25.88 $15,581 - $17,313
669 Added 2.36%
29,042 $739,000
Q2 2025

Jul 16, 2025
BUY
$21.59 - $24.84 $101,343 - $116,598
4,694 Added 19.82%
28,373 $687,000
Q1 2025

Apr 09, 2025
SELL
$25.01 - $27.13 $164,815 - $178,786
-6,590 Reduced 21.77%
23,679 $600,000
Q4 2024

Jan 10, 2025
BUY
$24.8 - $30.19 $111,972 - $136,307
4,515 Added 17.53%
30,269 $803,000
Q3 2024

Oct 18, 2024
SELL
$27.7 - $31.39 $35,871 - $40,650
-1,295 Reduced 4.79%
25,754 $745,000
Q2 2024

Jul 08, 2024
SELL
$25.26 - $29.6 $278,693 - $326,576
-11,033 Reduced 28.97%
27,049 $756,000
Q1 2024

Apr 02, 2024
BUY
$25.89 - $29.73 $3,935 - $4,518
152 Added 0.4%
38,082 $1.06 Million
Q4 2023

Jan 02, 2024
SELL
$26.13 - $33.94 $2.2 Million - $2.86 Million
-84,354 Reduced 68.98%
37,930 $1.09 Million
Q3 2023

Oct 23, 2023
SELL
$32.09 - $37.51 $574,796 - $671,879
-17,912 Reduced 12.78%
122,284 $4.06 Million
Q2 2023

Sep 07, 2023
SELL
$36.12 - $41.79 $6.53 Million - $7.56 Million
-180,848 Reduced 56.33%
140,196 $5.14 Million
Q4 2022

Feb 27, 2023
BUY
$41.75 - $54.5 $6.29 Million - $8.21 Million
150,714 Added 88.48%
321,044 $16.5 Million
Q2 2022

Aug 15, 2022
BUY
$46.53 - $55.17 $53,602 - $63,555
1,152 Added 0.68%
170,330 $8.93 Million
Q1 2022

May 12, 2022
SELL
$45.75 - $56.69 $37,560 - $46,542
-821 Reduced 0.48%
169,178 $8.76 Million
Q4 2021

Feb 11, 2022
BUY
$41.32 - $61.25 $401,589 - $595,288
9,719 Added 6.06%
169,999 $10 Million
Q3 2021

Nov 03, 2021
SELL
$39.25 - $50.42 $245,234 - $315,024
-6,248 Reduced 3.75%
160,280 $6.89 Million
Q1 2021

May 13, 2021
BUY
$33.49 - $37.77 $77,194 - $87,059
2,305 Added 1.4%
166,528 $6.03 Million
Q4 2020

Feb 04, 2021
BUY
$33.47 - $42.56 $135,319 - $172,070
4,043 Added 2.52%
164,223 $6.05 Million
Q3 2020

Nov 10, 2020
BUY
$31.75 - $37.25 $783,812 - $919,590
24,687 Added 18.22%
160,180 $5.88 Million
Q2 2020

Aug 13, 2020
SELL
$30.12 - $36.54 $2.73 Million - $3.31 Million
-90,590 Reduced 40.07%
135,493 $4.43 Million
Q1 2020

May 13, 2020
SELL
$27.03 - $38.62 $115,499 - $165,023
-4,273 Reduced 1.85%
226,083 $7.38 Million
Q4 2019

Feb 14, 2020
BUY
$32.92 - $37.36 $3.91 Million - $4.44 Million
118,736 Added 106.38%
230,356 $9.03 Million
Q3 2019

Oct 17, 2019
BUY
$32.49 - $42.13 $52,666 - $68,292
1,621 Added 1.47%
111,620 $4.01 Million
Q2 2019

Jul 24, 2019
SELL
$36.98 - $41.52 $96,517 - $108,367
-2,610 Reduced 2.32%
109,999 $4.77 Million
Q1 2019

May 02, 2019
SELL
$37.5 - $41.2 $210,712 - $231,502
-5,619 Reduced 4.75%
112,609 $4.78 Million
Q4 2018

Feb 05, 2019
SELL
$38.47 - $43.86 $40,739 - $46,447
-1,059 Reduced 0.89%
118,228 $5.16 Million
Q3 2018

Oct 23, 2018
SELL
$34.47 - $41.81 $213,265 - $258,678
-6,187 Reduced 4.93%
119,287 $5.26 Million
Q2 2018

Aug 07, 2018
SELL
$32.98 - $35.16 $2,209 - $2,355
-67 Reduced 0.05%
125,474 $4.55 Million
Q1 2018

Apr 20, 2018
BUY
$31.91 - $37.02 $140,180 - $162,628
4,393 Added 3.63%
125,541 $4.46 Million
Q4 2017

Feb 13, 2018
SELL
$33.26 - $35.29 $22,117 - $23,467
-665 Reduced 0.55%
121,148 $4.39 Million
Q3 2017

Oct 31, 2017
BUY
$31.0 - $34.15 $3.78 Million - $4.16 Million
121,813
121,813 $4.35 Million

Others Institutions Holding PFE

# of Institutions
3,314
Shares Held
3.65B
Call Options Held
96.6M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $138B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track St Germain D J CO Inc Portfolio

Follow St Germain D J CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St Germain D J CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on St Germain D J CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email